Showing results (1851-1860 of 2,055) with videos related to
Sort By:
Pageof 206
International Journal of Environmental Research and Public Health|August 7, 2021
COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-AnalysisCarolyn Ingram, Vicky Downey, Mark Roe, et al.Maturitas|December 30, 2025
Patient satisfaction and experiences with menopause care for people with autoimmune diseases: an international mixed-methods study from the Menopause MATTERs ProjectKaira Kuhu Naidu, Sydnae Taylor, Arvind Kaul, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
DNA methylation signatures in airway cells from adult children of asthmatic mothers reflect subtypes of severe asthmaKevin M Magnaye, Selene M Clay, Jessie Nicodemus-Johnson, et al.Nature Communications|May 1, 2019
A dynamic thermoregulatory material inspired by squid skinErica M Leung, Melvin Colorado Escobar, George T Stiubianu, et al.Annals of Neurology|October 27, 2018
Meningeal inflammation and cortical demyelination in acute multiple sclerosisRyan J Bevan, Rhian Evans, Lauren Griffiths, et al.Neuro-Oncology|May 15, 2015
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigueBrandi R Page, Edward G Shaw, Lingyi Lu, et al.Stem Cell Reports|December 16, 2022
Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fateAria L Byrd, Xufeng Qu, Alexsandr Lukyanchuk, et al.Cytotherapy|April 11, 2020
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalitiesSara Azhari Mohamed, Linda Howard, Veronica McInerney, et al.Journal of Neuroinflammation|September 13, 2024
Permethrin exposure primes neuroinflammatory stress response to drive depression-like behavior through microglial activation in a mouse model of Gulf War IllnessSean X Naughton, Eun-Jeong Yang, Umar Iqbal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.Pageof 206